Fig. 2

Higher levels of SH3PXD2B expression are associated with shorter survival periods of HCC patients. a, b All HCC patients were stratified, according to their TNM stages or pathological grades and the levels of SH3PXD2B mRNA transcripts were analyzed. Data are shown as the box and whisker plot, and the lines indicate the means of each group. c, d HCC patients were stratified, according to the median value of SH3PXD2B mRNA transcripts and their overall survival (OS) and recurrence-free survival (RFS) were analyzed by the Kaplan–Meier method and the log-rank test. e, f The OS and RFS of 89 HCC patients were analyzed after stratification of them into higher and lower SH3PXD2B expression with the least P value of OS, determined using the X-Tile software